HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For "Index Participants" (the first person recruited into the study):
- Must be 18 years old or older
- Must have used drugs in the past month
- Must know other people in their social circle who also use drugs
- Must be willing to talk with at least 2 people they know who use drugs about HIV testing and services, and try to refer them to the study
- Must speak English fluently
For "Peer-Recruit Participants" (people referred into the study by an Index Participant):
- Must be 18 years old or older
- Must have used drugs in the past 3 months
- Must have been referred to the study by an Index Participant, shown by presenting a recruitment coupon
- Must speak English fluently
Who may not be able to join:
- People who previously took part in the earlier research activities used to develop the program being tested in this trial will not be eligible to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Heather A Pines, San Diego State University
Phone: 619-594-2481
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
HIV testing (past 3 months); Linkage to PrEP/HIV care (past 3 months); PrEP/ART uptake (past 3 months)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.